Gary Taylor

Stock Analyst at TD Cowen

(1.99)
# 3,080
Out of 5,124 analysts
148
Total ratings
50.51%
Success rate
-0.32%
Average return

Stocks Rated by Gary Taylor

Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44$25
Current: $13.37
Upside: +86.99%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $23.05
Upside: +82.21%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $2.15
Upside: +481.40%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6$2
Current: $0.65
Upside: +208.64%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $193.94
Upside: +38.19%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $21.74
Upside: -40.20%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $501.69
Upside: -12.30%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $276.65
Upside: +120.13%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $38.46
Upside: +131.41%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $131.72
Upside: +186.97%
Maintains: Hold
Price Target: $183$220
Current: $218.56
Upside: +0.66%
Maintains: Hold
Price Target: $139$150
Current: $140.83
Upside: +6.51%
Maintains: Outperform
Price Target: $30$26
Current: $21.99
Upside: +18.24%
Upgrades: Outperform
Price Target: $39$35
Current: $13.56
Upside: +158.11%
Maintains: Outperform
Price Target: $564$585
Current: $338.98
Upside: +72.58%
Maintains: Market Perform
Price Target: $3$6
Current: $12.24
Upside: -50.98%
Maintains: Outperform
Price Target: $10$8
Current: $6.83
Upside: +17.13%
Upgrades: Outperform
Price Target: $242$329
Current: $292.05
Upside: +12.65%
Upgrades: Market Perform
Price Target: $7$3
Current: $2.13
Upside: +40.85%
Initiates: Market Perform
Price Target: $17
Current: $8.36
Upside: +103.35%
Downgrades: Underweight
Price Target: $28$20
Current: $201.37
Upside: -90.07%
Maintains: Neutral
Price Target: $33$20
Current: $20.89
Upside: -4.26%
Downgrades: Underweight
Price Target: n/a
Current: $3.15
Upside: -